What if prescription costs were tied to outcomes and how patients do on their prescriptions? It's already happening. Eric Elliott, president of CignaPharmacy Management, tells the Chicago Tribune's Bruce Japsen about new ways health benefits companies are working to provide more effective treatments.
Putting a Price on Quality When it Comes to Prescriptions

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
What if prescription costs were tied to outcomes and how patients do on their prescriptions? It's already happening. Eric Elliott, president of CignaPharmacy Management, tells the Chicago Tribune's Bruce Japsen about new ways health benefits companies are working to provide more effective treatments.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
Love Story: Lipid Education for Women’s Heart Health
Biomarkers of the Storm: Decoding IRI’s Signature
HF Management for Patients with Comorbid Conditions
Level Up Your Skills: Tailoring Management of HF
Navigating Myasthenia Gravis in Adolescents and Young Adults
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?